Advertisement
Advertisement

KVUE

KVUE logo

Kenvue Inc.

17.36
USD
Sponsored
-0.07
-0.37%
Apr 10, 15:59 UTC -4
Closed
exchange

After-Market

17.38

+0.01
+0.06%

Kenvue Inc. Profile

About

Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.

Info & Links

CEO

Kirk L. Perry

Headquarters

1 KENVUE WAY
SUMMIT, NJ 07901, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

2,817

Employees

22,000

Kenvue Inc. Statistics

Valuation Measures

Market Capitalization2

33.30B

Enterprise Value

40.77B

Enterprise Value/EBITDA(ttm)

13.72

Price to Earnings Ratio(ttm)

16.14

Price to Sales(ttm)

2.21

Price to Book(mrq)

3.10

Price to Cash(ytd)

12.64

Profitability

Gross Margin(ttm)

58.13%

Operating Margin(ttm)

13.75%

Profit Margin(ttm)

9.71%

Return on Equity(ttm)

19.72%

Return on Invested Capital(ttm)

8.43%

Return on Assets(ttm)

7.72%

Income Statement

Revenue(ttm)

15.12B

Revenue Per Share(ttm)

7.89

Gross Profit(ttm)

8.79B

EBITDA(ttm)3

2.97B

Net Income Available to Common(ttm)

1.47B

Diluted EPS(ttm)

0.77

Share Statistics

Beta (5Y Monthly)

0.61

52-Week Change

-20.27%

S&P 500 52-Week Change

27.10%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.92B

Dividend Yield

4.76%

Float4

1.88B

% Held by Insiders

1.68%

% Held by Institutions

97.64%

Balance Sheet

Total Cash(mrq)

1.06B

Total Cash Per Share(mrq)

0.55

Total Debt(mrq)

8.52B

Total Debt/Equity(mrq)

79.18%

Current Ratio(mrq)

0.96%

Quick Ratio(mrq)

0.68%

Book Value Per Share(mrq)

5.62

Cash Flow

Operating Cash Flow Per Share(ytd)

1.14

Free Cash Flow(ytd)

1.75B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement